KDM4B and fatty liver disease: The present observation of the significant elevation of JMJD2B expression in the livers of HFD-induced obese mice concomitant with increased PPARγ2 expression provided evidence of the crucial role of JMJD2B–PPARγ2 signaling in HFD-induced hepatic steatosis.